Chikara Oyama

Hirosaki University

Papers

1

Total Citations

48

H-Index

1

About

Dr. Chikara Oyama is a leading figure in urologic oncology, with a focused expertise in minimally invasive renal surgery. His most impactful work centers on the surgical management of complex renal tumors, particularly those located at the renal hilum. Dr. Oyama’s major contribution is his pioneering prospective, multi-institutional study comparing robot-assisted partial nephrectomy (RAPN) against standard laparoscopic partial nephrectomy (LPN) for these challenging hilar tumors. This landmark 2020 trial, involving 22 academic hospitals, provided critical evidence that RAPN offers superior outcomes for tumor removal in anatomically difficult cases, directly influencing surgical guidelines. With his top-cited paper garnering 48 citations, Dr. Oyama’s work has become a cornerstone for surgeons debating the optimal approach for nephron-sparing surgery. His rigorous, multi-center methodology has set a new standard for evaluating surgical techniques, demonstrating that robotic assistance can safely expand the indications for partial nephrectomy. For students and researchers, Dr. Oyama exemplifies how high-quality, collaborative clinical trials can directly translate into improved patient care and shape the future of urologic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
48
Total Citations
48
Avg Citations/Paper
🏆 Most Cited Paper
Robot‐assisted partial nephrectomy versus standard laparoscopic partial nephrectomy for renal hilar tumor: A prospective multi‐institutional study
48 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Hirosaki University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago